Genzyme Japan Launches Oral Gaucher’s Disease Treatment Cerdelga

September 2, 2015
Genzyme Japan rolled out Japan’s first oral Gaucher’s disease treatment Cerdelga capsules 100 mg (eliglustat tartrate) on September 1, it said on the same day. The drug is indicated for improvement in the symptoms associated with Gaucher’s disease (anemia, thrombopenia,...read more